Akorn’s Inapsine Set To Return To U.S. Market In June
This article was originally published in The Pink Sheet Daily
Executive Summary
The company has inked a hospital supply contract for the anesthetic droperidol.
You may also be interested in...
Akorn Expands Commercialization Agreement With Indian Partner Natco
The specialty pharma adds a first-line advanced breast cancer treatment to the deal to commercialize two oral cancer generics.
Akorn Expands Commercialization Agreement With Indian Partner Natco
The specialty pharma adds a first-line advanced breast cancer treatment to the deal to commercialize two oral cancer generics.
Akorn Expands Commercialization Agreement With Indian Partner Natco
Akorn has expanded a purchase and supply agreement it struck in March with Natco Pharma Limited to commercialize generic oncology products, the company announced Nov. 27